Jfl Life Sciences Limited

NSE: JFLLIFE · Unclassified

₹11.80+4.89%06 Nov 2026

Ask the data

Instant answers about Jfl Life Sciences Limited — computed from its filings, no language model

Market cap₹39 cr

Current price₹11.80

High / Low₹15 / ₹9

P/E4.9

P/B0.76

Book value₹15.5

ROE15.4%

ROCE15.6%

Debt / equity0.42

Dividend yield—

EPS (TTM)₹2.39

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY25	FY26
Revenue	42.8	46.5	82.0	131.4
EBITDA	3.9	4.5	8.2	11.7
Operating margin	9.2%	9.8%	10.0%	8.9%
Interest	1.4	0.8	1.1	2.1
Depreciation	0.4	0.4	1.0	1.1
Profit before tax	3.7	3.8	6.1	8.6
Tax	0.9	0.3	2.0	2.2
Net profit	2.8	3.5	4.2	6.4
EPS ₹	2.90	3.01	1.26	1.94
Operating cash flow	-9.1	8.4	-3.5	-4.3
Capex	-0.2	6.1	0.4	3.4
Dividend paid	0.0	0.0	0.3	0.0
Total assets	—	—	71.9	106.2
Equity	—	—	39.5	45.9

Quarterly performance

last 7 quarters · ₹ crore

	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26*	JUN '26	SEP '26
Revenue	11.7	11.6	29.9	26.8	36.2	11.1	98.7
Operating profit	1.4	1.9	2.9	3.4	0.2	2.1	6.7
Operating margin	11.8%	16.7%	9.7%	12.5%	0.5%	18.8%	6.7%
Other income	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest	0.3	0.2	0.4	0.4	0.7	0.3	0.7
Depreciation	0.4	0.3	0.3	0.3	0.0	0.3	0.3
Profit before tax	0.7	1.4	2.2	2.7	-0.5	1.5	5.7
Tax	0.6	0.7	0.2	0.7	-0.1	0.4	1.4
Net profit	0.1	0.8	2.0	2.0	-0.4	1.1	5.1
EPS ₹	0.03	0.23	0.60	0.61	-0.11	0.34	1.28
Revenue YoY	—	—	—	—	208.7%	-4.2%	229.8%
Profit YoY	—	—	—	—	-550.0%	48.0%	159.1%

Returns & margins

trailing-twelve-month, per quarter

	DEC '25	MAR '26	JUN '26	SEP '26
ROE	11.5%	9.6%	10.4%	15.4%
ROCE	15.8%	11.3%	11.4%	15.6%
Net margin	6.0%	4.2%	4.6%	4.6%
EBITDA margin	12.0%	8.0%	8.2%	7.1%
Debt / equity	0.27	0.47	0.47	0.42
Interest coverage	6.07	4.45	4.37	5.67
Asset turnover	0.94	0.98	0.98	1.16

Balance sheet

equity vs borrowings over time · ₹ crore

	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	11.0	33.0	33.0	33.0	33.0
Other equity / reserves	27.9	6.5	9.2	12.9	18.2
Total equity	38.9	39.5	42.2	45.9	51.2
Borrowings	10.5	10.6	11.2	21.7	21.6
Current liabilities	44.7	31.6	42.7	53.0	87.8
Non-current liabilities	0.8	0.8	0.7	7.4	10.3
Total assets	84.4	71.9	85.6	106.2	149.3
Property, plant & equipment	12.2	12.2	9.2	14.5	11.3
Capital work-in-progress	—	—	2.6	—	—
Investments	0.0	0.0	0.0	0.0	0.0
Inventories	18.2	23.2	33.2	34.5	33.7
Receivables	50.0	35.0	36.6	53.3	90.4
Cash & equivalents	0.3	0.0	1.6	0.9	0.2

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY25	FY26
Cash from operations	-9.1	8.4	-3.5	-4.3
Cash from investing	0.9	-6.1	-0.0	-3.9
Cash from financing	8.1	-2.3	3.5	9.1
Capex	-0.2	6.1	0.4	3.4
Free cash flow	-8.8	2.3	-3.9	-7.7
Dividends paid	0.0	0.0	0.3	0.0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹11.3 cr8%

Inventories

₹33.7 cr23%

Receivables

₹90.4 cr61%

Cash & equivalents

₹0.2 cr0%

Other assets

₹13.8 cr9%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Jfl Life Sciences Limited	39	11.80	4.9	0.76	15.4%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+14.0%

6 months+15.1%

1 year-25.8%

3Y CAGR-38.1%

5Y CAGR—

10Y CAGR—

50-day avg₹10.83

200-day avg₹10.88

RSI (14)63

FAQs

What is the share price of Jfl Life Sciences Limited?

Jfl Life Sciences Limited (JFLLIFE) closed at ₹11.80 on NSE on 06 Nov 2026.

What is the market cap of Jfl Life Sciences Limited?

₹39 crore at the latest close.

What is the P/E ratio of Jfl Life Sciences Limited?

4.9, on trailing-twelve-month earnings from its filings.

How fast is Jfl Life Sciences Limited growing?

Jfl Life Sciences Limited: revenue has compounded at 45.3% a year over three years; net profit at 31.6% a year. Latest-quarter revenue is up 229.8% year on year, profit up 159.1%.

How profitable is Jfl Life Sciences Limited?

On a trailing-twelve-month basis return on equity is 15.4%, return on capital employed 15.6%, operating margin 7.1%, net margin 4.6%.

How much debt does Jfl Life Sciences Limited have?

Jfl Life Sciences Limited is lightly geared: debt to equity is 0.42 with borrowings of ₹22 cr against cash of ₹0 cr (balance sheet of 2026-09-30). Operating profit covers interest 5.7 times.

Financials parsed from Jfl Life Sciences Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from MAR '25, annual from FY23, balance sheet from Sep '24. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.